Ringdén OT - Search Results

1

Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.

Inamoto Y, Flowers ME, Wang T, Urbano-Ispizua A, Hemmer MT, Cutler CS, Couriel DR, Alousi AM, Antin JH, Gale RP, Gupta V, Hamilton BK, Kharfan-Dabaja MA, Marks DI, Ringdén OT, Socié G, Solh MM, Akpek G, Cairo MS, Chao NJ, Hayashi RJ, Nishihori T, Reshef R, Saad A, Shah A, Teshima T, Tallman MS, Wirk B, Spellman SR, Arora M, Martin PJ. Inamoto Y, et al. Among authors: ringden ot. Biol Blood Marrow Transplant. 2015 Oct;21(10):1776-82. doi: 10.1016/j.bbmt.2015.05.023. Epub 2015 May 30. Biol Blood Marrow Transplant. 2015. PMID: 26033280 Free PMC article.

2

Allogeneic bone marrow transplantation: the Huddinge experience.

Ringdén O. Ringdén O. Transplant Proc. 1992 Feb;24(1):371-3. Transplant Proc. 1992. PMID: 1311477 No abstract available.

3

Correlation of pretransplant viral serology and complications of bone marrow transplantation.

Ringdén O. Ringdén O. Ann Hematol. 1992 Jun;64 Suppl:A143-7. doi: 10.1007/BF01715369. Ann Hematol. 1992. PMID: 1322186 Review.

4

Prevention and therapy of graft-versus-host disease. Report from a work-shop.

Ringdén O, Kersey JH. Ringdén O, et al. Bone Marrow Transplant. 1992;10 Suppl 1:22-4. Bone Marrow Transplant. 1992. PMID: 1355684 No abstract available.

5

Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy.

Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringdén O, et al. Biggs JC, et al. Blood. 1992 Aug 15;80(4):1090-3. Blood. 1992. PMID: 1498326 Free article.

6

Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease.

Mattsson T, Heimdahl A, Dahllöf G, Lönnquist B, Ringdén O. Mattsson T, et al. Oral Surg Oral Med Oral Pathol. 1992 Jul;74(1):34-40. doi: 10.1016/0030-4220(92)90212-9. Oral Surg Oral Med Oral Pathol. 1992. PMID: 1508507

7

Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.

Ringdén O, Klaesson S, Sundberg B, Ljungman P, Lönnqvist B, Persson U. Ringdén O, et al. Bone Marrow Transplant. 1992 Jan;9(1):19-25. Bone Marrow Transplant. 1992. PMID: 1543946

8

Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?

Horowitz MM, Przepiorka D, Champlin RE, Gale RP, Gratwohl A, Herzig RH, Prentice HG, Rimm AA, Ringdén O, Bortin MM. Horowitz MM, et al. Blood. 1992 May 15;79(10):2771-4. Blood. 1992. PMID: 1586723 Free article. Clinical Trial.

9

Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.

Aschan J, Ringdén O, Sundberg B, Gahrton G, Ljungman P, Winiarski J. Aschan J, et al. Bone Marrow Transplant. 1991 Feb;7(2):113-9. Bone Marrow Transplant. 1991. PMID: 2049554 Clinical Trial.

10

Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.

Ringdén O, Pihlstedt P, Markling L, Aschan J, Båryd I, Ljungman P, Lönnqvist B, Tollemar J, Janossy G, Sundberg B. Ringdén O, et al. Bone Marrow Transplant. 1991 Mar;7(3):221-6. Bone Marrow Transplant. 1991. PMID: 2059758 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

749 results

Search Page

Filters